SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/12/20 AMERI Holdings, Inc. S-4/A 113:17M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size 1: S-4/A Pre-Effective Amendment to Registration Statement HTML 5.25M - Securities for a Merger 2: EX-23.4 Consent of Expert or Counsel HTML 29K 3: EX-23.5 Consent of Expert or Counsel HTML 29K 4: EX-99.2 Miscellaneous Exhibit HTML 30K 5: EX-99.3 Miscellaneous Exhibit HTML 31K 6: EX-99.4 Miscellaneous Exhibit HTML 31K 7: EX-99.5 Miscellaneous Exhibit HTML 31K 8: EX-99.6 Miscellaneous Exhibit HTML 31K 9: EX-99.7 Miscellaneous Exhibit HTML 31K 16: R1 Document and Entity Information HTML 43K 17: R2 Condensed Consolidated Balance Sheets HTML 137K 18: R3 Condensed Consolidated Balance Sheets HTML 47K (Parenthetical) 19: R4 Condensed Consolidated Statements of Operations HTML 144K and Comprehensive Income (Loss) 20: R5 Consolidated Statement of Changes in Stockholders' HTML 116K Equity 21: R6 Condensed Consolidated Statements of Cash Flows HTML 113K 22: R7 Description of Business HTML 39K 23: R8 Summary of Significant Accounting Policies HTML 93K 24: R9 Basis of Presentation HTML 36K 25: R10 Equity Transactions HTML 50K 26: R11 Business Combinations HTML 89K 27: R12 Revenue Recognition HTML 41K 28: R13 Intangible Assets HTML 45K 29: R14 Goodwill HTML 37K 30: R15 Share-Based Compensation HTML 34K 31: R16 Equity Compensation Plans HTML 67K 32: R17 Warrants Outstanding HTML 46K 33: R18 Earnings (Loss) Per Share HTML 54K 34: R19 Incentive Plan Items HTML 31K 35: R20 Bank Debt HTML 34K 36: R21 Debt HTML 42K 37: R22 Accrued Expenses and Other Current Liabilities HTML 35K 38: R23 Employee Benefit Plan HTML 31K 39: R24 Income Taxes HTML 44K 40: R25 Leases HTML 46K 41: R26 Convertible Notes HTML 34K 42: R27 Commitments and Contingencies HTML 48K 43: R28 Fair Value Measurement HTML 53K 44: R29 Revision of Prior Year Financial Statements HTML 102K 45: R30 Preferred Stock HTML 32K 46: R31 Secured Note HTML 32K 47: R32 Subsequent Events HTML 63K 48: R33 Summary of Significant Accounting Policies HTML 147K (Policies) 49: R34 Summary of Significant Accounting Policies HTML 37K (Tables) 50: R35 Business Combinations (Tables) HTML 62K 51: R36 Earnings (Loss) Per Share (Tables) HTML 49K 52: R37 Commitments and Contingencies (Tables) HTML 60K 53: R38 Warrants Outstanding (Tables) HTML 48K 54: R39 Intangible Assets (Tables) HTML 45K 55: R40 Goodwill (Tables) HTML 35K 56: R41 Equity Compensation Plans (Tables) HTML 66K 57: R42 Debt (Tables) HTML 35K 58: R43 Accrued Expenses and Other Current Liabilities HTML 34K (Tables) 59: R44 Income Taxes (Tables) HTML 38K 60: R45 Leases (Tables) HTML 60K 61: R46 Fair Value Measurement (Tables) HTML 47K 62: R47 Revision of Prior Year Financial Statements HTML 99K (Tables) 63: R48 Description of Business (Details Narrative) HTML 31K 64: R49 Description of Business (Details Narrative) (10-K) HTML 55K 65: R50 Summary of Significant Accounting Policies HTML 43K (Details Narrative) (10-K) 66: R51 Summary of Significant Accounting Policies - HTML 48K Schedule of Disaggregation of Revenue (Details) 67: R52 Equity Transactions (Details Narrative) (10-K) HTML 117K 68: R53 Business Combinations (Details Narrative) HTML 69K 69: R54 Business Combinations (Details Narrative) (10-K) HTML 115K 70: R55 Business Combinations - Summary of Foregoing HTML 83K Acquisitions (Details) 71: R56 Intangible Assets (Details Narrative) HTML 32K 72: R57 Intangible Assets (Details Narrative) (10-K) HTML 37K 73: R58 Intangible Assets - Schedule of Components of HTML 39K Intangible Assets (Details) (10-K) 74: R59 Intangible Assets - Schedule of Future HTML 38K Amortization of Intangible Assets (Details) (10-K) 75: R60 Goodwill (Details Narrative) HTML 32K 76: R61 Goodwill (Details Narrative) (10-K) HTML 32K 77: R62 Goodwill - Schedule of Goodwill (Details) (10-K) HTML 35K 78: R63 Share-Based Compensation (Details Narrative) HTML 37K (10-K) 79: R64 Equity Compensation Plans (Details Narrative) HTML 38K (10-K) 80: R65 Equity Compensation Plans - Schedule of Option HTML 72K Activity (Details) (10-K) 81: R66 Earnings (Loss) Per Share - Schedule of Earnings HTML 65K Per Share Basic and Diluted (Details) 82: R67 Incentive Plan Items (Details Narrative) HTML 31K 83: R68 Bank Debt (Details Narrative) HTML 45K 84: R69 Debt (Details Narrative) (10-K) HTML 75K 85: R70 Debt - Schedule of Short Term Debt (10-K) HTML 37K (Details) 86: R71 Accrued Expenses and Other Current Liabilities - HTML 44K Schedule of Accrued Expenses and Other Liabilities (Details) (10-K) 87: R72 Employee Benefit Plan (Details Narrative) (10-K) HTML 36K 88: R73 Income Taxes (Details Narrative) (10-K) HTML 36K 89: R74 Income Taxes - Schedule of Provision for Income HTML 52K Tax (10-K) (Details) 90: R75 Convertible Notes (Details Narrative) HTML 53K 91: R76 Commitments and Contingencies (Details Narrative) HTML 39K 92: R77 Commitments and Contingencies - Schedule of HTML 35K Components of Lease Expense (Details) 93: R78 Commitments and Contingencies - Schedule of HTML 38K Supplemental Balance Sheet Information Related to Leases (Details) 94: R79 Commitments and Contingencies - Schedule of HTML 39K Supplemental Cash Flow and Other Information Related to Leases (Details) 95: R80 Commitments and Contingencies - Schedule of HTML 49K Maturity Payments of Operating Leases (Details) 96: R81 Warrants Outstanding - Schedule of Warrant HTML 45K Outstanding (Details) 97: R82 Warrants Outstanding - Schedule of Warrants HTML 52K Activity (Details) (10-K) 98: R83 Preferred Stock (Details Narrative) HTML 39K 99: R84 Secured Note (Details Narrative) HTML 35K 100: R85 Leases (Details Narrative) (10-K) HTML 34K 101: R86 Leases - Schedule of Components of Lease Expense HTML 35K (Details) (10-K) 102: R87 Leases - Schedule of Supplemental Balance Sheet HTML 38K Information Related to Leases (Details) (10-K) 103: R88 Leases - Schedule of Supplemental Cash Flow and HTML 39K Other Information Related to Leases (Details) (10-K) 104: R89 Leases - Schedule of Maturity Payments of HTML 44K Operating Leases (Details) (10-K) 105: R90 Fair Value Measurement - Schedule of Financial HTML 40K Assets Measured at Fair Value (10-K) (Details) 106: R91 Fair Value Measurement - Schedule of Fair Value HTML 39K Change in Levels (10-K) (Details) 107: R92 Revision of Prior Year Financial Statements - HTML 133K Schedule of Consolidated Financial Statements Previously (Details) 108: R93 Revision of Prior Year Financial Statements - HTML 138K Schedule of Consolidated Financial Statements Previously (Details) (10-K) 109: R94 Subsequent Events (Details Narrative) HTML 55K 110: R95 Leases - Schedule of Supplemental Cash Flow and HTML 39K Other Information Related to Leases (Details) 112: XML IDEA XML File -- Filing Summary XML 205K 111: EXCEL IDEA Workbook of Financial Reports XLSX 151K 10: EX-101.INS XBRL Instance -- amrh-20200331 XML 2.20M 12: EX-101.CAL XBRL Calculations -- amrh-20200331_cal XML 211K 13: EX-101.DEF XBRL Definitions -- amrh-20200331_def XML 644K 14: EX-101.LAB XBRL Labels -- amrh-20200331_lab XML 1.16M 15: EX-101.PRE XBRL Presentations -- amrh-20200331_pre XML 993K 11: EX-101.SCH XBRL Schema -- amrh-20200331 XSD 235K 113: ZIP XBRL Zipped Folder -- 0001493152-20-015374-xbrl Zip 203K
Exhibit 99.2
August 12th, 2020
The Board of Directors
Ameri Holdings, Inc.
5000
Research Court
Suite 750
Suwanee, GA 30024
Board of Directors
Members of the Board:
We hereby consent to the inclusion of our opinion letters, dated August 7, 2020 to the Board of Directors of Ameri Holdings, Inc (“Ameri”) in the registration statement on Form S-4 being filed on August 12, 2020 (the “Registration Statement”), and to the references made to our firm and such opinion in the Registration Statement. Notwithstanding the foregoing, in giving such consent, we do not admit and we hereby disclaim that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder, nor do we hereby admit that we are experts with respect to any part of such Registration Statement within the meaning of the term “experts” as used in the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission promulgated thereunder.
Very truly yours,
/s/ Mohit Pareek
Gemini Valuation Services
C:
This ‘S-4/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 8/12/20 | 10-K/A, 8-K, CORRESP | ||
8/7/20 | ||||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/06/21 Enveric Biosciences, Inc. 8-K:1,2,3,512/30/20 13:1M M2 Compliance LLC/FA 11/10/20 Enveric Biosciences, Inc. S-4/A 121:18M M2 Compliance LLC/FA 11/09/20 Enveric Biosciences, Inc. S-4/A 122:18M M2 Compliance LLC/FA 10/22/20 Enveric Biosciences, Inc. S-4/A 123:18M M2 Compliance LLC/FA 9/17/20 Enveric Biosciences, Inc. S-4/A 9/16/20 118:18M M2 Compliance LLC/FA |